';

The NanoMedicine Center, “NANOMIB” of the University of Milano-Bicocca, is a biotech platform whose mission is the design, synthesis and validation of nano-devices for regenerative medicine, therapy and diagnosis of human diseases.
Nanomib’s mission is to accelerate the path from laboratory experimentation to the application of new methods in human diagnostic and therapeutics of many diseases that are still largely untreated today: “from the bench to the bedside”, promoting an effective link with pharmaceutical and medical industries. The Center brings together the skills of Milano-Bicocca researchers in various research areas (chemistry, materials, physics, biophysics, biochemistry, biology, physiology, biotechnology, informatics, statistics, toxicology, and almost all clinical specializations) and different Departments (Medicine and Surgery, Biotechnology and Biosciences, Physics, Materials Science Informatics, Environmental and Earth Sciences) to create new models of care and prevention in the field of therapy, diagnostics and regenerative medicine.

The activities of the Center are reflected in scientific publications, participation in national and international research projects, Conferences and – in the field of technology transfer – patenting, patent licensing and creation of Spin-Offs. The researchers of the Center are also involved in the development of human capital within several PhD programs at the University of Milano-Bicocca (programs in Translational Medicine, Nanostructures and Nanotechnologies, Material Science, Physics…) also in co-tutorship with international universities (e.g. University of Pays Basques, San Sebastian DIPC (Spain); University of Porto; University of Sao Paulo (Brazil)).

Courses in “Nanomedicine” are also given by the researchers of the Center within the Master degrees of “ Industrial Technology” and “Medical biotechnologies”